UDP-glucuronosyltransferase 1-9
Details
- Name
- UDP-glucuronosyltransferase 1-9
- Synonyms
- 2.4.1.17
- GNT1
- lugP4
- UDP-glucuronosyltransferase 1-I
- UDP-glucuronosyltransferase 1A9
- UDPGT 1-9
- UGT-1I
- UGT1
- UGT1I
- Gene Name
- UGT1A9
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0006817|UDP-glucuronosyltransferase 1-9 MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLILRGHEVVVVMP EVSWQLGRSLNCTVKTYSTSYTLEDLDREFKAFAHAQWKAQVRSIYSLLMGSYNDIFDLF FSNCRSLFKDKKLVEYLKESSFDAVFLDPFDNCGLIVAKYFSLPSVVFARGILCHYLEEG AQCPAPLSYVPRILLGFSDAMTFKERVRNHIMHLEEHLLCHRFFKNALEIASEILQTPVT EYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIV VFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGH PMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDL ENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTW YQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
- Number of residues
- 530
- Molecular Weight
- 59940.495
- Theoretical pI
- 7.96
- GO Classification
- Functionsenzyme binding / enzyme inhibitor activity / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid bindingProcessescellular glucuronidation / cellular lipid metabolic process / cellular response to hormone stimulus / flavone metabolic process / flavonoid biosynthetic process / flavonoid glucuronidation / metabolic process / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / retinoic acid metabolic process / small molecule metabolic process / xenobiotic glucuronidation / xenobiotic metabolic processComponentsendoplasmic reticulum / endoplasmic reticulum membrane / extracellular exosome / integral component of membrane
- General Function
- Retinoic acid binding
- Specific Function
- UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.
- Pfam Domain Function
- UDPGT (PF00201)
- Transmembrane Regions
- 488-504
- Cellular Location
- Microsome
- Gene sequence
>lcl|BSEQ0012464|UDP-glucuronosyltransferase 1-9 (UGT1A9) ATGGCTTGCACAGGGTGGACCAGCCCCCTTCCTCTATGTGTGTGTCTGCTGCTGACCTGT GGCTTTGCCGAGGCAGGGAAGCTACTGGTAGTGCCCATGGATGGGAGCCACTGGTTCACC ATGAGGTCGGTGGTGGAGAAACTCATTCTCAGGGGGCATGAGGTGGTTGTAGTCATGCCA GAGGTGAGTTGGCAACTGGGAAGATCACTGAATTGCACAGTGAAGACTTATTCAACTTCA TATACCCTGGAGGATCTGGACCGGGAGTTCAAGGCTTTTGCCCATGCTCAATGGAAAGCA CAAGTACGAAGTATATATTCTCTATTAATGGGTTCATACAATGACATTTTTGACTTATTT TTTTCAAATTGCAGGAGTTTGTTTAAAGACAAAAAATTAGTAGAATACTTAAAGGAGAGT TCTTTTGATGCAGTGTTTCTCGATCCTTTTGATAACTGTGGCTTAATTGTTGCCAAATAT TTCTCCCTCCCCTCCGTGGTCTTCGCCAGGGGAATACTTTGCCACTATCTTGAAGAAGGT GCACAGTGCCCTGCTCCTCTTTCCTATGTCCCCAGAATTCTCTTAGGGTTCTCAGATGCC ATGACTTTCAAGGAGAGAGTACGGAACCACATCATGCACTTGGAGGAACATTTATTATGC CACCGTTTTTTCAAAAATGCCCTAGAAATAGCCTCTGAAATTCTCCAAACACCTGTTACG GAGTATGATCTCTACAGCCACACATCAATTTGGTTGTTGCGAACGGACTTTGTTTTGGAC TATCCCAAACCCGTGATGCCCAACATGATCTTCATTGGTGGTATCAACTGCCATCAGGGA AAGCCGTTGCCTATGGAATTTGAAGCCTACATTAATGCTTCTGGAGAACATGGAATTGTG GTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCTATGGCAATTGCT GATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGAACCCGACCATCG AATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGATCTGCTTGGTCAC CCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTATGAAAGCATATGC AATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGACAATGCAAAGCGC ATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACTTCTGAAGATTTA GAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAACATCATGCGCCTC TCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTGTTCTGGGTGGAG TTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCACGACCTCACCTGG TACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTGCTGACAGTGGCC TTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGGAAAAAAGGGCGA GTTAAGAAAGCCCACAAATCCAAGACCCATTGA
- Chromosome Location
- 2
- Locus
- 2q37
- External Identifiers
Resource Link UniProtKB ID O60656 UniProtKB Entry Name UD19_HUMAN GenBank Protein ID 7690346 GenBank Gene ID S55985 HGNC ID HGNC:12541 - General References
- Wooster R, Sutherland L, Ebner T, Clarke D, Da Cruz e Silva O, Burchell B: Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family. Biochem J. 1991 Sep 1;278 ( Pt 2):465-9. [Article]
- Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article]
- Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article]
- Tang L, Singh R, Liu Z, Hu M: Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm. 2009 Sep-Oct;6(5):1466-82. doi: 10.1021/mp8002557. [Article]
- Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article]
- Nakajima M, Koga T, Sakai H, Yamanaka H, Fujiwara R, Yokoi T: N-Glycosylation plays a role in protein folding of human UGT1A9. Biochem Pharmacol. 2010 Apr 15;79(8):1165-72. doi: 10.1016/j.bcp.2009.11.020. Epub 2009 Nov 29. [Article]
- Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article]
- Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]
- Menard V, Girard H, Harvey M, Perusse L, Guillemette C: Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. Hum Mutat. 2009 Apr;30(4):677-87. doi: 10.1002/humu.20946. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00398 Sorafenib approved, investigational unknown substrateinhibitor Details DB00328 Indomethacin approved, investigational unknown substrate Details DB00494 Entacapone approved, investigational unknown substrate Details DB00749 Etodolac approved, investigational, vet_approved unknown substrate Details DB00762 Irinotecan approved, investigational unknown substrate Details DB00818 Propofol approved, investigational, vet_approved unknown substrate Details DB01024 Mycophenolic acid approved, investigational unknown substrate Details DB00313 Valproic acid approved, investigational unknown substrate Details DB00502 Haloperidol approved unknown substrate Details DB00744 Zileuton approved, investigational, withdrawn unknown substrate Details DB00712 Flurbiprofen approved, investigational unknown substrate Details DB01050 Ibuprofen approved unknown substrate Details DB01283 Lumiracoxib approved, investigational unknown substrate Details DB00580 Valdecoxib approved, investigational, withdrawn unknown substrate Details DB00731 Nateglinide approved, investigational unknown substrate Details DB06739 Seratrodast experimental unknown substrate Details DB06741 Gavestinel investigational unknown substrate Details DB06738 Ketobemidone investigational unknown substrate Details DB06403 Ambrisentan approved, investigational unknown substrate Details DB00197 Troglitazone approved, investigational, withdrawn unknown substrate Details DB00688 Mycophenolate mofetil approved, investigational unknown substrate Details DB04824 Phenolphthalein approved, withdrawn unknown Details DB04552 Niflumic acid experimental unknown Details DB06235 Vadimezan investigational unknown substrate Details DB04953 Ezogabine approved, investigational unknown substrate Details DB06204 Tapentadol approved unknown substrate Details DB06695 Dabigatran etexilate approved unknown substrate Details DB08896 Regorafenib approved unknown substrateinhibitor Details DB08907 Canagliflozin approved unknown substrate Details DB00316 Acetaminophen approved unknown substrate Details DB00842 Oxazepam approved unknown substrate Details DB06292 Dapagliflozin approved no substrate Details DB01685 Topiroxostat experimental unknown substrate Details DB05016 Ataluren approved, investigational no substrate Details DB13874 Enasidenib approved, investigational unknown substrate Details DB08930 Dolutegravir approved no substrate Details DB11827 Ertugliflozin approved, investigational no substrate Details DB11638 Artenimol approved, experimental, investigational no substrate Details DB11633 Isavuconazole approved, investigational unknown inhibitor Details DB09285 Morniflumate experimental unknown inhibitor Details DB12010 Fostamatinib approved, investigational unknown substrate Details DB01039 Fenofibrate approved no substrate Details DB01320 Fosphenytoin approved, investigational no inhibitor Details DB00252 Phenytoin approved, vet_approved no substrateinhibitor Details DB09288 Propacetamol experimental no substrate Details DB01609 Deferasirox approved, investigational unknown inhibitor Details DB09213 Dexibuprofen approved, investigational unknown substrate Details DB06210 Eltrombopag approved no inhibitor Details DB00784 Mefenamic acid approved no inhibitor Details DB00861 Diflunisal approved, investigational no inhibitor Details DB04552 Niflumic acid experimental no inhibitor Details DB01045 Rifampicin approved unknown inhibitor Details DB11978 Glasdegib approved, investigational no substrate Details DB00788 Naproxen approved, vet_approved unknown substrate Details DB00586 Diclofenac approved, vet_approved unknown substrate Details DB00598 Labetalol approved unknown substrate Details DB01241 Gemfibrozil approved unknown substrate Details DB12941 Darolutamide approved, investigational unknown Details DB00983 Formoterol approved, investigational unknown substrate Details DB00977 Ethinylestradiol approved unknown substrate Details DB13609 Umifenovir investigational unknown substrateinhibitor Details DB09241 Methylene blue approved, investigational unknown inhibitor Details DB09038 Empagliflozin approved unknown substrate Details DB09274 Artesunate approved, investigational unknown substrate Details DB00935 Oxymetazoline approved, investigational no substrate Details DB15456 Vericiguat approved, investigational unknown substrate Details DB11751 Cabotegravir approved, investigational unknown substrate Details DB04854 Febuxostat approved no substrate Details DB16703 Belumosudil approved, investigational no substrateinhibitor Details DB12713 Sotagliflozin approved, investigational no substrate Details DB04847 Roxadustat approved, investigational unknown substrate Details DB09061 Cannabidiol approved, investigational no substrateinhibitor Details DB14737 Cannabinol experimental, investigational unknown substrateinhibitor Details DB14009 Medical Cannabis experimental, investigational unknown substrateinhibitor Details DB09185 Viloxazine approved, investigational, withdrawn no substrate Details DB16650 Deucravacitinib approved, investigational unknown substrate Details DB00470 Dronabinol approved, illicit no substrate Details DB12243 Edaravone approved, investigational no substrate Details DB12236 Bexagliflozin approved, investigational unknown substrate Details DB17472 Pirtobrutinib approved, investigational unknown substrate Details DB06045 Trofinetide approved, investigational unknown inhibitor Details DB12255 Vadadustat approved, investigational unknown substrate Details DB11763 Momelotinib approved, investigational unknown inhibitor Details DB00555 Lamotrigine approved, investigational unknown substrate Details DB00503 Ritonavir approved, investigational no inducer Details DB14635 Curcumin sulfate experimental unknown inhibitor Details DB00794 Primidone approved, vet_approved unknown inducer Details DB00783 Estradiol approved, investigational, vet_approved unknown substrateinducer Details DB00714 Apomorphine approved, investigational unknown substrate Details DB11796 Fostemsavir approved, investigational unknown substrate Details DB00871 Terbutaline approved unknown substrate Details DB00960 Pindolol approved, investigational unknown substrate Details DB12471 Ibrexafungerp approved, investigational unknown substrate Details